Start for free
Start for free
M Ventures logo

M Ventures

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.

Investor Profile

M Ventures has made 135 investments, with 19 in the past 12 months and 39% as lead.

Stage Focus

  • Series A (44%)
  • Series B (21%)
  • Seed (18%)
  • Series C (7%)
  • Series Unknown (7%)
  • Series D (1%)
  • Pre Seed (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (41%)
  • United Kingdom (17%)
  • Switzerland (13%)
  • Germany (8%)
  • France (5%)
  • The Netherlands (4%)
  • Israel (3%)
  • Denmark (3%)
  • Finland (2%)
  • Singapore (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
  • Biopharma
  • Semiconductor
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does M Ventures frequently co-invest with?

Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 9
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 8
Taiho Ventures
Taiho Ventures
North America, California, United States, California City
Co-Investments: 7
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 11
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 11
MP Healthcare Venture Management
MP Healthcare Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
EQT Life Sciences
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
Sofinnova Partners
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 8
Inkef
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 7

Which angels does M Ventures often collaborate with?

EL
Edward Lando
North America, Florida, United States, Miami Beach
Shared Deals: 1
NP
Neil Parikh
North America, New York, United States, New York
Shared Deals: 1
JR
Josh Resnick
North America, California, United States, Los Angeles
Shared Deals: 1
David Baszucki
David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1
CL
Cory Levy
North America, California, United States, San Francisco
Shared Deals: 1
MD
Meltem Demirors
North America, New York, United States, New York
Shared Deals: 1
JM
John Maloney
North America, New York, United States, New York
Shared Deals: 1
RP
Robert Pittman
North America, New York, United States, New York
Shared Deals: 1
CC
Colin Carrier
North America, California, United States, Los Angeles
Shared Deals: 1
Lev Leviev
Lev Leviev
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 1

What are some of recent deals done by M Ventures?

MemryX

Ann Arbor, Michigan, United States

MemryX is an AI chip startup developing an innovative Edge AI Accelerator.

Artificial Intelligence (AI)Information TechnologySoftware
Series BMar 27, 2025
Amount Raised: $44,000,000
TRIMTECH Therapeutics

Cambridge, Massachusetts, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

BiotechnologyMedicalTherapeutics
SeedMar 5, 2025
Amount Raised: $31,000,000
NovoLINC

Pittsburgh, Pennsylvania, United States

NovoLINC is a pioneering startup that provides thermal interface solutions.

NanotechnologySemiconductor
SeedJan 21, 2025
SeeQC

Elmsford, New York, United States

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

ElectronicsInfrastructureManufacturingQuantum ComputingSemiconductor
Series AJan 14, 2025
Amount Raised: $30,000,000
Abselion

Cambridge, Cambridgeshire, United Kingdom

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Biotechnology
Series ADec 4, 2024
Amount Raised: $8,382,496
IonKraft

Aachen, Nordrhein-Westfalen, Germany

IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse.

Machinery Manufacturing
SeedNov 18, 2024
Amount Raised: $3,708,091
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000
Enara Bio

London, England, United Kingdom

Ervaxx is illuminating the immune interface to develop new cancer therapies.

BiotechnologyHealth CareTherapeutics
Series BOct 3, 2024
Amount Raised: $32,500,000
PictorLabs

Los Angeles, California, United States

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareHealth DiagnosticsSoftware
Series BSep 18, 2024
Amount Raised: $30,000,000
NanoSyrinx

Coventry, Coventry, United Kingdom

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

BiotechnologyMedicalTherapeutics
Series ASep 10, 2024
Amount Raised: $13,079,777
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator